OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026

Contributed by: Business Wire

Tags

Health
Clinical Trials
Research
Pharmaceutical
Science
Biotechnology
OM Pharma

More Like This

ACCESSWIRE logo

EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)

ACCESSWIRE logo

Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345

ACCESSWIRE logo

Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)

ACCESS Newswire logo

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA)

Orexo to present clinical data for OX640 at the EAACI Congress

Business Wire logo

Renovion Announces Positive Top-Line Results from Phase 2 CLIMB Study of ARINA-1 (RVN-301) in Patients with Non-Cystic Fibrosis Bronchiectasis

New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms